Molecular pharmacology, regulation and function of mammalian melatonin receptors

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Dubocovich, Margarita L ^a,b,c   Rivera Bermudez, Moises A ^a   Gerdin, Matthew J ^a,c   Masana, Monica I ^a,c  

^a Dept Molec Pharmacol Biol Chem ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

4P PDOT; Circadian rhythms; G protein coupled receptors; Luzindole; MT1; MT2 and MT3 melatonin receptors; Review

Indexed keywords

2 IODOMELATONIN; 5 METHOXYLUZINDOLE; 6 CHLOROMELATONIN; 6,7 DICHLORO 2 METHYLMELATONIN; AGOMELATINE; DOPAMINE; LEUKOTRIENE B4; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR; MELATONIN RECEPTOR 3; N ACETYLSEROTONIN; N ACETYLTRYPTAMINE; PROLACTIN; UNCLASSIFIED DRUG;

BINDING AFFINITY; BIOASSAY; CARDIOVASCULAR FUNCTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CIRCADIAN RHYTHM; DOPAMINE RELEASE; HUMORAL IMMUNITY; HYPOPHYSIS PARS TUBERALIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNITY; INFLAMMATION; INTRAOCULAR PRESSURE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MAMMAL; MICROVASCULATURE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NERVE CONDUCTION; NONHUMAN; PROLACTIN RELEASE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RETINA; REVIEW; SUPRACHIASMATIC NUCLEUS; TEMPERATURE; VASOCONSTRICTION; VASODILATATION;

MAMMALIA;

EID: 3242662870     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Masana M. I. and M. L. Dubocovich: Melatonin receptor signaling: finding the path through the dark. Sci STKE 2001, E39 (2001)
2. McCord C. P. and F. P. Allen: Evidence associating pineal gland function with alterations in pigmentation. J Exp Zool 23, 207-224 (1917)
3. Lerner A. B., J. D. Case and R. V. Heinzelman: Structure of melatonin. J Am Chem Soc 81, 6084-6085 (1959)
4. Bernard M., J. Guerlotte, P. Greve, A. Grechez-Cassiau, M. P. Iuvone, M. Zatz, N. W. Chong, D. C. Klein and P. Voisin: Melatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina. Reprod Nutr Dev 39, 325-334 (1999)
5. Klein D., S. Coon, P. Roseboom, J. Weller, M. Bernard, J. Gastel, M. Zatz, P. Iuvone, I. Rodriguez, V. Begay, J. Falcon, G. Cahill, V. Cassone and R. Baler: The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res 52, 307-357; discussion 357-308 (1997)
6. Tosini G. and M. Menaker: Circadian rhythms in cultured mammalian retina. Science 272, 419-421 (1996)
7. Borjigin J., X. Li and S. H. Snyder: The pineal gland and melatonin: molecular and pharmacologic regulation. Annu Rev Pharmacol Toxicol 39, 53-65 (1999)
8. Brzezinski A.: Melatonin in humans. W Engl J Med 336, 186-195 (1997)
9. Vanecek J. and K. Watanabe: Mechanisms of melatonin action in the pituitary and SCN. Adv Exp Med Biol 460, 191-198 (1999)
10. Heward C. B. and M. E. Hadley: Structure-activity relationships of melatonin and related indoleamines. LifeSci 17, 1167-1177 (1975)
11. White B. H., R. D. Sekura and M. D. Rollag: Pertussis toxin blocks melatonin-induced pigment aggregation in Xenopus dermal melanophores. J Comp Physiol [B] 157, 153-159 (1987)
12. Cardinali D. P., M. I. Vacas and E. E. Boyer: Specific binding of melatonin in bovine brain. Endocrinology 105, 437-441 (1979)
13. Dubocovich M. L.: Melatonin is a potent modulator of dopamine release in the retina. Nature 306, 782-784 (1983)
14. Dubocovich M. L.: Role of melatonin in retina. Progress in Retinal Research 8, 129-151 (1988)
15. Dubocovich M.: Pharmacology and function of melatonin receptors. FASEB J 2, 2765-2773 (1988)
16. Dubocovich M. L.: Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16, 50-56 (1995)
17. Reppert S. M., D. R. Weaver and T. Ebisawa: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13, 1177-1185 (1994)
18. 1b melatonin receptor. Proceedings of the National Academy of Sciences USA 92, 8734-8738 (1995)
19. Dubocovich M. L., D. P. Cardinali, P. Delagrange, D. N. Krause, A. D. Strosberg, D. Sudgen and F. D. Yocca: Melatonin Receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. 2nd Edition. Ed: D. Girdlestone, IUPHAR Media, London, (2000)
20. Ebisawa T., S. Karne, M. R. Lerner and S. M. Reppert: Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A 91, 6133-6137 (1994)
21. Reppert S. M., D. R. Weaver and C. Godson: Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 17, 100-102 (1996)
22. Navajas C., T. Kokkola, A. Poso, N. Honka, J. Gynther and J. T. Laitinen: A rhodopsin-based model for melatonin recognition at its G protein- coupled receptor. Eur J Pharmacol 304, 173-183 (1996)
23. Wess J.: Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci 14, 308-313 (1993)
24. Nelson C. S., M. Ikeda, H. S. Gompf, M. L. Robinson, N. K. Fuchs, T. Yoshioka, K. A. Neve and C. N. Allen: Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124. Mol Endocrinol 15, 1306-1317 (2001)
25. Gubitz A. K. and S. M. Reppert: Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding. Endocrinology 141, 1236-1244 (2000)
26. Conway S., J. E. Drew, E. S. Mowat, P. Barrett, P. Delagrange and P. J. Morgan: Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor. J Biol Chem 275, 20602-20609 (2000)
27. 1 receptor. Biochem Biophys Res Commun 282, 1229-1236 (2001)
28. 2 receptor. Eur J Pharmacol 449, 29-38 (2002)
29. Kenakin T.: Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 1, 103-110 (2002)
30. Heward C. B. and M. E. Hadley: Structure-activity relationships of melatonin and related indoleamines. Life Sci 17, 1167-1178 (1975)
31. Krause D. N., V. E. Barrios and S. P. Duckles: Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 276, 207-213 (1995)
32. 2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 280, C110-118 (2001)
33. 2 receptors. Br J Pharmacol 129, 877-886 (2000)
34. 1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol Pharmacol 50, 166-174 (1996)
35. Dubocovich M. L. and M. I. Masana: The efficacy of melatonin receptor analogues is dependent on the level of human melatonin receptor subtype expression. In: Biological Clocks. Mechanisms and applications. Eds: Y. Touitou, Elsevier Science, Amsterdam, The Netherlands, 289-293 (1998)
36. 35S]-GTPgammaS binding. Biochem Pharmacol 56, 1167-1174. (1998)
37. 1 receptors in male rat caudal arteries. Eur J Pharmacol 439, 171-172 (2002)
38. 2 melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. Biochem Pharmacol 63, 587-595 (2002)
39. Kenakin T.: Pharmacologic Analysis of Drug-Receptor Interaction, Raven Press, New York, NY, (1993)
40. Dubocovich M. L.: Characterization of a retinal melatonin receptor. J Pharmacol Exp Ther 234, 395-401 (1985)
41. 1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Arch Pharmacol 355, 365-375 (1997)
42. 125I] iodomelatonin to characterize melatonin binding sites in chicken retina. Proc Natl Acad Sci U S A 84, 3916-3920 (1987)
43. 125I]-iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice. Eur J Pharmacol 180, 387-390 (1990)
44. 2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 12, 1211-1220 (1998)
45. Sugden D., L. K. Yeh and M. T. Teh: Design of subtype selective melatonin receptor agonists and antagonists. Reprod Nutr Dev 39, 335-344 (1999)
46. Dubocovich M. L.: Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 246, 902-910 (1988)
47. i: precoupling and constitutive activity. Mol Pharmacol 56, 1014-1024 (1999)
48. Witt-Enderby P. A., M. I. Masana and M. L. Dubocovich: Physiological exposure to melatonin supersensitizes the cyclic adenosine 3′,5′- monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. Endocrinology 139, 3064-3071 (1998)
49. q/11 proteins. Mol Endocrinol 13, 2025-2038 (1999)
50. 1a receptor. Neuroreport 11, 1803-1807 (2000)
51. 2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal 14, 249-257 (2002)
52. 1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138, 397-404 (1997)
53. Nelson C. S., J. L. Marino and C. N. Allen: Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport 7, 717-720 (1996)
54. 1 melatonin receptor. Cell Motil Cytoskeleton 46, 28-42 (2000)
55. 1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway. Biochem Pharmacol 58, 633-639 (1999)
56. 1b receptors. Nature Neurosci 2, 401-403 (1999)
57. Jin X., C. von Gall, R. L. Pieschl, V. K. Gribkoff, J. H. Stehle, S. M. Reppert and D. R. Weaver: Targeted Disruption of the Mouse Mel1b Melatonin Receptor. Mol. Cell. Biol. 23, 1054-1060 (2003)
58. Gauer F., M. Masson-Pevet and P. Pevet: Melatonin receptor density is regulated in rat pars tuberalis and suprachiasmatic nuclei by melatonin itself. Brain Res 602, 153-156 (1993)
59. Tenn C. and L. P. Niles: Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress. Mol Cell Endocrinol 98, 43-48 (1993)
60. 2 melatonin receptors upon prolonged withdrawal. Biochem Pharmacol In Press, (2003)
61. Ferguson S. S.: Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53, 1-24 (2001)
62. Hazlerigg D. G., A. Gonzalez-Brito, W. Lawson, M. H. Hastings and P. J. Morgan: Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 132, 285-292 (1993)
63. 2 melatonin receptors. J. Pharmacol. Exp. Ther. In Press (2003)
64. Roy D., N. L. Angelini, H. Fujieda, G. M. Brown and D. D. Belsham: Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology 142, 4711-4720 (2001)
65. 2 binding sites. Eur J Pharmacol 301, 159-168 (1996)
66. Popova J. S. and M. L. Dubocovich: Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J Neurochem 64, 130-138 (1995)
67. Eison A. S. and U. L. Mullins: Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci 53, L393-398 (1993)
68. 3 as the quinone reductase 2. J Biol Chem 275, 31311-31317 (2000)
69. Lotufo C. M., C. Lopes, M. L. Dubocovich, S. H. Farsky and R. P. Markus: Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 430, 351-357 (2001)
70. 3 receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol 416, 251-254 (2001)
71. Kenakin T. P.: Efficacy: molecular mechanisms and operational methods of measurement. A new algorithm for the prediction of side effects. In: Handbook of Experimental Pharmacology: The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems. Eds: J. A. Angus and T. P. Kenakin, Springer-Verlag, Berlin-Heidelberg, Germany 148, 183-259 (2000)
72. Doolen S., D. N. Krause, M. L. Dubocovich and S. P. Duckles: Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345, 67-69 (1998)
73. 2 melatonin receptors are present and functional in rat caudal artery. J Pharmacol ExpTher 302, 1295-1302 (2002)
74. Doolen S., D. N. Krause and S. P. Duckles: Estradiol modulates vascular response to melatonin in rat caudal artery. Am J Physiol 276, H1281-1288 (1999)
75. 1 melatonin receptor. FASEB J. 12, 894 (1998)
76. 2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Br J Pharmacol 127, 1288-1294 (1999)
77. Foord S. M. and F. H. Marshall: RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 20, 184-187 (1999)
78. Devi L. A.: Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 22, 532-537 (2001)
79. Ayoub M. A., C. Couturier, E. Lucas-Meunier, S. Angers, P. Fossier, M. Bouvier and R. Jockers: Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277, 21522-21528 (2002)
80. Vanecek J., A. Pavlik and H. Illnerova: Hypothalamic melatonin receptor sites revealed by autoradiography. Brain Res 435, 359-362 (1987)
81. 1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin. Neuroscience 93, 793-799 (1999)
82. Al-Ghoul W. M., M. D. Herman and M. L. Dubocovich: Melatonin receptor subtype expression in human cerebellum. Neuroreport 9, 4063-4068 (1998)
83. Vanecek J.: Cellular mechanisms of melatonin action. Physiol Rev 78, 687-721. (1998)
84. Liu C., D. R. Weaver, X. Jin, L. P. Shearman, R. L. Pieschl, V. K. Gribkoff and S. M. Reppert: Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19, 91-102 (1997)
85. Mazzucchelli C., M. Pannacci, R. Nonno, V. Lucini, F. Fraschini and B. M. Stankov: The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res Mol Brain Res 39, 117-126 (1996)
86. Scher J., E. Wankiewicz, G. M. Brown and H. Fujieda: MT(1) melatonin receptor in the human retina: expression and localization. Invest Ophthalmol Vis Sci 43, 889-897 (2002)
87. Poirel V. J., M. Masson-Pevet, P. Pevet and F. Gauer: MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei. Brain Res 946, 64-11 (2002)
88. Fujieda H., J. Scher, S. A. Hamadanizadeh, E. Wankiewicz, S. F. Pang and G. M. Brown: Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina. Vis Neurosci 17, 63-70 (2000)
89. Meyer P., M. Pache, K. U. Loeffler, L. Brydon, R. Jockers, J. Flammer, A. Wirz-Justice and E. Savaskan: Melatonin MT-1-receptor immunoreactivity in the human eye. Br J Ophthalmol 86, 1053-1057 (2002)
90. Savaskan E., A. Wirz-Justice, G. Olivieri, M. Pache, K. Krauchi, L. Brydon, R. Jockers, F. Muller-Spahn and P. Meyer: Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem 50, 519-526 (2002)
91. Gillette M. U. and J. W. Mitchell: Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res 309, 99-107 (2002)
92. Foster R. G., I. Provencio, D. Hudson, S. Fiske, W. De Grip and M. Menaker: Circadian photoreception in the retinally degenerate mouse (rd/rd). J Comp Physiol [A] 169, 39-50 (1991)
93. Bellingham J. and R. G. Foster: Opsins and mammalian photoentrainment. Cell Tissue Res 309, 57-71 (2002)
94. Provencio I., M. D. Rollag and A. M. Castrucci: Photoreceptive net in the mammalian retina. This mesh of cells may explain how some blind mice can still tell day from night. Nature 415, 493 (2002)
95. Hattar S., H. W. Liao, M. Takao, D. M. Berson and K. W. Yau: Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295, 1065-1070 (2002)
96. Reppert S. M. and D. R. Weaver: Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63, 647-676 (2001)
97. Moore R. Y.: Neural control of the pineal gland. Behav Brain Res 73, 125-130 (1996)
98. Mason R. and A. Brooks: The electrophysiological effects of melatonin and a putative melatonin antagonist (N-acetyltryptamine) on rat suprachiasmatic neurones in vitro. Neurosci Lett 95, 296-301 (1988)
99. Shibata S., V. M. Cassone and R. Y. Moore: Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro. Neurosci Lett 97, 140-144 (1989)
100. Starkey S. J., M. P. Walker, I. J. M. Beresford and R. M. Hagan: Modulation of the rat suprachiasmatic circadianclock by melatonin in vitro. Neuroreport 6, 1947-1951 (1995)
101. Gillette M. U. and A. J. McArthur: Circadian actions of melatonin at the suprachiasmatic nucleus. Behav Brain Res 73, 135-139 (1996)
102. Jiang Z. G., C. S. Nelson and C. N. Allen: Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons. Brain Res 687, 125-132 (1995)
103. Benloucif S., M. I. Masana and M. L. Dubocovich: Responsiveness to melatonin and its receptor expression in the aging circadian clock of mice. Am J Physiol 273, R1855-1860 (1997)
104. Lewy A. J., V. K. Bauer, S. Ahmed, K. H. Thomas, N. L. Cutler, C. M. Singer, M. T. Moffit and R. L. Sack: The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 15, 71-83 (1998)
105. McArthur A. J., M. U. Gillette and R. A. Prosser: Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 565, 158-161 (1991)
106. McArthur J. J., A. E. Hunt and M. U. Gillette: Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138, 627-634 (1997)
107. Dubocovich M. L.: Therapeutic potential of melatonin receptor agonists and antagonists. Emerging drugs 4, 153-173 (1999)
108. Vanecek J. and L. Vollrath: Developmental changes and daily rhythm in melatonin-induced inhibition of 3′,5′-cyclic AMP accumulation in the rat pituitary. Endocrinology 126, 1509-1513 (1990)
109. Martin J. E., S. McKellar and D. C. Klein: Melatonin inhibition of the in vivo pituitary response to luteinizing hormone-releasing hormone in the neonatal rat. Neuroendocrinology 31, 13-17 (1980)
110. Vanecek J. and D. C. Klein: Melatonin inhibition of GnRH-induced LH release from neonatal rat gonadotroph: involvement of Ca2+ not cAMP. Am J Physiol 269, E85-90 (1995)
111. Yie S. M., L. P. Niles and E. V. Younglai: Melatonin receptors on human granulosa cell membranes. J Clin Endocrinol Metab 80, 1747-1749 (1995)
112. 1 melatonin receptors in rat ovary following estrogen exposure. Life Sci 69, 27-35 (2001)
113. Niles L. P., J. Wang, L. Shen, D. K. Lobb and E. V. Younglai: Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol 156, 107-110 (1999)
114. Brzezinski A., M. M. Seibel, H. J. Lynch, M. H. Deng and R. J. Wurtman: Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 64, 865-867 (1987)
115. Ronnberg L., A. Kauppila, J. Leppaluoto, H. Martikainen and O. Vakkuri: Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 71, 492-496 (1990)
116. Sirotkin A. V. and H. J. Schaeffer: Direct regulation of mammalian reproductive organs by serotonin and melatonin. J Endocrinol 154, 1-5 (1997)
117. Tamarkin L., C. J. Baird and O. F. Almeida: Melatonin: a coordinating signal for mammalian reproduction? Science 227, 714-720 (1985)
118. Reiter R. J.: The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1, 109-131 (1980)
119. Malpaux B., M. Migaud, H. Tricoire and P. Chemineau: Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J Biol Rhythms 16, 336-347 (2001)
120. von Gall C., M. L. Garabette, C. A. Kell, S. Frenzel, F. Dehghani, P. M. Schumm-Draeger, D. R. Weaver, H. W. Korf, M. H. Hastings and J. H. Stehle: Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat Neurosci 5, 234-238 (2002)
121. Viswanathan M., J. T. Laitinen and J. M. Saavedra: Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci U S A 87, 6200-6203 (1990)
122. Stankov B., S. Capsoni, V. Lucini, J. Fauteck, S. Gatti, B. Gridelli, G. Biella, B. Cozzi and F. Fraschini: Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus. Neuroscience 52, 459-468 (1993)
123. Ting K. N., N. A. Blaylock, D. Sugden, P. Delagrange, E. Scalbert and V. G. Wilson: Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 127, 987-995 (1999)
124. Geary G. G., S. P. Duckles and D. N. Krause: Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors. Br J Pharmacol 123, 1533-1540 (1998)
125. Nelson M. T. and J. M. Quayle: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268, C799-822 (1995)
126. Viswanathan M., E. Scalbert, P. Delagrange, B. Guardiola-Lemaitre and J. M. Saavedra: Melatonin receptors mediate contraction of a rat cerebral artery. Neuroreport 8, 3847-3849 (1997)
127. Mahle C. D., G. D. Goggins, P. Agarwal, E. Ryan and A. J. Watson: Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 12, 690-696 (1997)
128. Geary G. G., D. N. Krause and S. P. Duckles: Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol 273, H1530-1536 (1997)
129. Krauchi K., C. Cajochen, E. Werth and A. Wirz-Justice: Functional link between distal vasodilation and sleep-onset latency? Am J Physiol Regul Integr Comp Physiol 278, R741-748 (2000)
130. Nelson R. J. and D. L. Drazen: Melatonin mediates seasonal changes in immune function. Ann N Y Acad Sci 917, 404-415 (2000)
131. Drazen D. L., S. L. Klein, S. M. Yellon and R. J. Nelson: In vitro melatonin treatment enhances splenocyte proliferation in prairie voles. J Pineal Res 28, 34-40 (2000)
132. 1a) Is Associated with Melatonin-Induced Enhancement of Cell-Mediated and Humoral Immunity. Neuroendocrinology 74, 178-184 (2001)
133. Caroleo M. C., D. Frasca, G. Nistico and G. Doria: Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23, 81-89 (1992)
134. Lopes C., J. L. deLyra, R. P. Markus and M. Mariano: Circadian rhythm in experimental granulomatous inflammation is modulated by melatonin. J Pineal Res 23, 72-78 (1997)